Short-term adverse events following modified vaccinia Ankara–Bavarian Nordic (MVA-BN) mpox vaccine with and without concomitant vaccines, Australia, 2022 to 2023

Thuy Nguyen, Kristine Macartney, Nicholas Wood, Lucy Dawes, Lucy Deng

Open source

DOI
10.2807/1560-7917.es.2026.31.44.2600181
Published
2026-11-05
Container
Eurosurveillance
Publisher
European Centre for Disease Control and Prevention (ECDC)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2807/1560-7917.es.2026.31.44.2600181,
  title = {Short-term adverse events following modified vaccinia Ankara–Bavarian Nordic (MVA-BN) mpox vaccine with and without concomitant vaccines, Australia, 2022 to 2023},
  author = {Thuy Nguyen and Kristine Macartney and Nicholas Wood and Lucy Dawes and Lucy Deng},
  year = {2026},
  journal = {Eurosurveillance},
  doi = {10.2807/1560-7917.es.2026.31.44.2600181},
  url = {https://doi.org/10.2807/1560-7917.es.2026.31.44.2600181}
}

RIS

TY  - JOUR
TI  - Short-term adverse events following modified vaccinia Ankara–Bavarian Nordic (MVA-BN) mpox vaccine with and without concomitant vaccines, Australia, 2022 to 2023
AU  - Thuy Nguyen
AU  - Kristine Macartney
AU  - Nicholas Wood
AU  - Lucy Dawes
AU  - Lucy Deng
PY  - 2026
JO  - Eurosurveillance
DO  - 10.2807/1560-7917.es.2026.31.44.2600181
UR  - https://doi.org/10.2807/1560-7917.es.2026.31.44.2600181
ER  - 

APA

Nguyen, T., Macartney, K., Wood, N., Dawes, L., & Deng, L. (2026). Short-term adverse events following modified vaccinia Ankara–Bavarian Nordic (MVA-BN) mpox vaccine with and without concomitant vaccines, Australia, 2022 to 2023. Eurosurveillance. https://doi.org/10.2807/1560-7917.es.2026.31.44.2600181

Source records